Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

Share Price is delayed by 15 minutes
Get Live Data
50.55    0.00 (0.00%)
Bid:
49.60
Ask:
51.50
Spread: 1.90 (3.831%)
Market Cap: £193.32m
BSC Live PriceLast checked at - London Stock Exchange

Intraday Br.small Co.2 Share Chart

Interim Management Statement

19 Nov 2008 10:48

RNS Number : 4691I
British SmallerTechCompaniesVCT2PLC
19 November 2008
 

BRITISH SMALLER TECHNOLOGY COMPANIES VCT 2 PLC ("the Company")

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 September 2008

British Smaller Technology Companies VCT 2 plc presents its interim management statement for the quarter ended 30 September 2008. This constitutes the Company's second interim management statement for the financial year ending 31 December 2008, as required by the UK Listing Authority's Disclosure and Transparency Rule 4.3.

The unaudited net asset value per Ordinary share as at 30 September 2008 was 79.7 pence. This is a decrease of 3.9% over the net asset value of 82.9 pence per share at 30 June 2008.  The reduction is largely attributed to the recognition of the special and interim dividend paid to shareholders in September and totalling 4 pence per share. Hence the total return, calculated by reference to the net asset value plus cumulative dividends paid has increased from 94.9p per share at 30 June 2008 to 95.7 pence per share at 30 September 2008, an increase of 0.8%.  

In addition to the dividend, the last three months have seen the value of the AiM portfolio depressed given the market conditions and a £94k reduction in the portfolio has been recognised.  This represents a 6% reduction in the value of the AiM portfolio during the quarter. A review of the unquoted portfolio has identified some ups and downs, but minimal net impact on the value of the unquoted portfolio overall. The reduction in the value of the AiM portfolio has been offset by the recovery in the market value of the gilts, which have increased £110k during the period. At 30 September 2008, the Company held cash and Gilts representing 42.5% of the net asset value. 

This quarter has seen the inclusion of £164,000 in respect of the reclaim for irrecoverable VAT in line with the ruling by HMRC.

There has been no movement in the number of Ordinary shares, 16,641,257 Ordinary shares being in issue at both 31 December 2007 and 30 June 2008.

The Company has completed one investment in the quarter, being a £52,000 follow on equity investment in Manchester based computer chip designer Silistix Limited Disposals of £3,500 related to the scheduled loan repayments made by RMS Group Limited.

Net assets at 30 September 2008 comprised the following:

£000

% of net assets

Unquoted investments at fair value

5,815

43.8

Quoted investments at bid price

1,519

11.5

Total venture capital investments

7,334

55.3

Cash and cash equivalents

5,633

42.5

Other net current assets

295

2.2

Net assets

13,262

100.0

The net asset value per Ordinary share at 30 September 2008 was 79.7 pence. The net asset value remains significantly in excess of the current share price.

The ten largest investments by valuation at 30 September 2008 were as follows:

£000

% of net assets

Digital Healthcare

1,650

12.5

Immunobiology

850

6.4

Silistix

719

5.4

Primal Pictures

642

4.8

Pressure Technologies

520

3.9

ART

484

3.7

RMS

435

3.3

Cater Plus

345

2.6

DxS

320

2.4

Harvey Jones

278

2.1

Top ten investments

6,243

47.1

Other investments

1,091

8.2

Total venture capital investments

7,334

55.3

Quoted investments are carried at bid price at 30 September 2008. Unquoted investment are carried at fair value as at 30 September 2008 as determined by the directors.

During the three months ended 30 September 2008 the following significant investment transactions took place (all companies are unquoted except where otherwise indicated):

Follow-on Investments:

Name of company:

Business activity:

Amount invested £000

Silistix Ltd

Silicon chip design

52

52

In this period the Company has seen its underlying net asset value increase by 0.8 pence per share after the payment of an interim dividend of 2 pence per share and a special dividend of 2 pence share. It is pleasing to note that the residual net asset value has both increased and currently comprises 42.5% in gilts and cash.

With the principal investments in the portfolio all having secured funding with little exposure to financial leverage the portfolio is itself well placed to take advantage of expansion opportunities as they arise.

There has been a marked increase in the number of investment opportunities being presented. The Company's liquidity is good but your board will be seeking to increase this through a non-prospectus top up offer early in the New Year.

 

19 November 2008

For further information please contact:

David Hall YFM Private Equity Tel: 0161 832 7603

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGUGMCGUPRGUB
Date   Source Headline
23rd Aug 20176:00 pmRNSHalf-year Report
26th Jun 201710:58 amRNSTransaction in Own Shares
12th May 201710:11 amRNSPayment of Final Dividend and Allotment of Shares
10th May 20172:57 pmRNSAGM Statement
10th May 20179:51 amRNSInterim Management Statement
13th Apr 20171:47 pmRNSTransaction in Own Shares
21st Mar 20171:25 pmRNSAnnual Financial Report
10th Feb 201710:47 amRNSIssue of Equity and Close of Offer
30th Jan 20172:07 pmRNSOffer for Subscription
10th Jan 201710:25 amRNSClose of Offer to new Subscriptions
3rd Jan 201711:59 amRNSOffer for Subscription
6th Dec 201610:06 amRNSChange of Stockbrokers
29th Nov 20169:46 amRNSPurchase of own securities and total voting rights
22nd Nov 20163:30 pmRNSInterim Management Statement
26th Sep 201610:30 amRNSPayment of Interim Dividend and Share Allotment
22nd Aug 201611:01 amRNSChange of auditor
11th Aug 20162:06 pmRNSHalf-year Report
8th Jul 201611:32 amRNSCompletion of new investment
15th Jun 20163:25 pmRNSTransaction in Own Shares
9th May 20169:53 amRNSPayment of Final Dividend and Allotment of Shares
6th May 20162:25 pmRNSResult of Annual General Meeting
6th May 201610:05 amRNSInterim Management Statement
27th Apr 20164:55 pmRNSPurchase of Own Securities and Total Voting Rights
24th Mar 20164:46 pmRNSTransaction in Own Shares
24th Mar 20162:58 pmRNSAnnual Financial Report
25th Feb 20163:13 pmRNSDisclosure of Home Member State
14th Jan 20162:23 pmRNSIssue of Equity and Close of Offer
23rd Dec 201510:21 amRNSClose of Offer to New Subscriptions
8th Dec 20152:10 pmRNSOffer for Subscription
23rd Nov 201512:24 pmRNSInterim Management Statement
28th Sep 201510:18 amRNSPayment of Interim Dividend and Allotment of Share
14th Aug 20152:18 pmRNSHalf Yearly Report
23rd Jun 20151:04 pmRNSTransaction in Own Shares
8th Jun 201510:08 amRNSIssue of Equity
18th May 20155:41 pmRNSResult of Annual General Meeting
15th May 201511:00 amRNSInterim Management Statement
6th May 20151:33 pmRNSPurchase of Own Securities and Total Voting Rights
22nd Apr 20152:01 pmRNSIssue of Equity and Close of Offers
10th Apr 20153:38 pmRNSOffers for Subscription - Supplementary Prospectus
31st Mar 20154:40 pmRNSCompletion of new investment
31st Mar 201511:53 amRNSIssue of Equity Replacement
31st Mar 20157:00 amRNSIssue of Equity
27th Mar 20157:00 amRNSAnnual Financial Report
24th Mar 20159:46 amRNSClose of Offers to New Applications
9th Mar 20154:24 pmRNSOver Allotment Facility
2nd Mar 20154:33 pmRNSIssue of Equity
3rd Feb 20157:00 amRNSIssue of Equity
6th Jan 20153:34 pmRNSIssue of Equity
31st Dec 20141:00 pmRNSTotal Voting Rights at 31 December 2014
22nd Dec 20143:15 pmRNSRealisation of Investment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.